New collaboration


The MERCUR Foundation granted funding for the collaborative research initiative "Targeting Cancer at the Interface of Genomics, Metabolism and Immune Surveillance (IGNITE)".

This initiative, which is driven by Daniel Rauh from the TU Dortmund and Christian Reinhardt from the University Hospital Essen, aims at delivering novel anti-cancer drugs and synergistically combines the translational cancer biology expertise in Essen with the medicinal chemistry and chemical biology stronghold in Dortmund. We are very much looking forward to this collaboration!